ECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logo
  • Home
  • Archives
  • Contact
✕
  • Filter by
  • Categories
  • Tags
  • Authors
  • Show all
  • All
  • Advocacy
  • Artificial intelligence (AI)
  • Brain cancer
  • Breast cancer
  • ComboMATCH
  • COVID-19
  • Gastrointestinal (GI) cancer
  • Genitourinary (GU) cancer
  • Head and neck cancer
  • Health equity
  • Imaging
  • Immunotherapy
  • In memory
  • Leukemia
  • Lung cancer
  • Lymphoma
  • Mammography
  • Melanoma
  • Myelodysplastic syndrome
  • Myeloma
  • NCI-MATCH
  • Older adults
  • Pancreatic cancer
  • Pancreatic cysts
  • Patient education
  • Patient navigation
  • Patient-reported outcomes
  • Personalized treatment
  • Precision medicine
  • Prevention
  • Prostate cancer
  • Real-world data
  • Real-world evidence
  • Research results
  • Sarcoma
  • Screening for cancer
  • Side effects
  • Survivorship
  • Targeted therapy
  • Young adults
June 7, 2020
June 7, 2020
Categories
  • New Trials

Now Enrolling: The CompassHER2 pCR trial is determining if certain patients with early-stage HER2 positive breast cancer may benefit from reduced chemotherapy

The purpose of this study is to find out if some patients with early-stage HER2 positive breast cancer can safely be treated with less chemotherapy than is generally used.
Do you like it?
0 Read more
February 9, 2020
green awareness ribbon hope
February 9, 2020
Categories
  • New Trials

Now Enrolling: Trial EA4181 is comparing three different chemotherapy treatments for newly diagnosed mantle cell lymphoma

Right now, researchers do not know the ideal treatment for people with newly diagnosed mantle cell lymphoma.
Do you like it?
0 Read more
October 14, 2019
October 14, 2019
Categories
  • New Trials

Now Enrolling: Trial EAZ171 is addressing an important survivorship issue…neuropathy in African American women with breast cancer

Recently Activated: Trial EAZ171 is addressing an important survivorship issue...neuropathy in African American women with breast cancer.
Do you like it?
0 Read more
Prev page
1234567

Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2026 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc